CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
They filed their motions with the FTC's in-house court and shared it with Reuters. The companies said Khan, along with Slaughter and Bedoya, displayed bias against pharmacy benefit managers and prejudged their pricing models.
Attorneys argue Khan and two other commissioners are biased against pharmacy benefit managers and should recuse themselves ...
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...
Splitting the healthcare company into stand-alone pharmacy or health insurance businesses could leave each struggling.
Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.
CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...
The Woonsocket, R.I.-based health care giant said it would cut more than 100 positions in January at its corporate office in ...
Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...
Only 153 of the terminated employees work at the Woonsocket headquarters or surrounding facilities while the remaining ...
Texas Attorney General Ken Paxton alleges several major manufacturers and pharmacy benefit managers have driven the costs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback